Synlab AG
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG00ZXRLR30
SYAB
Synlab AG
GICS: 35102015
·
Sector: -
·
Sub-Sector: -
NAME
Synlab AG
ISIN
DE000A2TSL71
TICKER
SYAB
MIC
XETR
REUTERS
SYAB.DE
BLOOMBERG
SYAB GR
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Wed, 30.10.2024
Cinven to Acquire Elliott’s Stake in SYNLAB AG, Squeeze-Out to Follow
Elliott to remain indirect minority shareholder in SYNLAB
The Management Board of SYNLAB AG (“SYNLAB”) has been informed that international private equity firm Cinven has reached an agreement with funds advised by Elliott Advisors (UK) Limited (“Elliott”). Under this agreement,...
Tue, 17.09.2024
Cinven to sell minority stake in SYNLAB to strategic investor Labcorp
International private equity firm, Cinven, has reached an agreement to sell an indirect minority stake in SYNLAB, a leader in medical diagnostic services and specialty testing in Europe, to strategic investor Labcorp. Labcorp is a global leader of innovative and comprehensive la...
Tue, 17.09.2024
Cinven to sell minority stake in SYNLAB to strategic investor Labcorp
International private equity firm, Cinven, has reached an agreement to sell an indirect minority stake in SYNLAB, a leader in medical diagnostic services and specialty testing in Europe, to strategic investor Labcorp. Labcorp is a global leader of innovative and comprehensive la...
Tue, 04.06.2024
Cybersecurity Incident at Synnovis in UK
SYNLAB AG ("SYNLAB", FSE: SYAB) confirms that Synnovis, a partnership between two London-based hospital Trusts and SYNLAB UK & Ireland, was the victim of a cyber-attack on 3 June 2024.
A taskforce of IT experts from Synnovis and the National Health Service in UK (NHS England) is working diligently to fu...
Fri, 31.05.2024
SYNLAB AG (“SYNLAB”; FSE: SYAB) has today signed a delisting agreement (“Delisting Agreement”) with Ephios Bidco GmbH, a subsidiary of Ephios Luxembourg S.à r.l., both holding companies controlled by investment funds advised by Cinven Limited.
Concurrently, Ephios BidCo GmbH announced its decision to make a public delisting acquisition offer to the...
Fri, 31.05.2024
SYNLAB AG (“SYNLAB”; FSE: SYAB) has today signed a delisting agreement (“Delisting Agreement”) with Ephios Bidco GmbH, a subsidiary of Ephios Luxembourg S.à r.l., both holding companies controlled by investment funds advised by Cinven Limited.
Concurrently, Ephios BidCo GmbH announced its decision to make a public delisting acquisition offer to the...
Fri, 31.05.2024
EQS-WpÜG: Ephios Bidco GmbH / Tender Offer
Tender Offer / Target company: SYNLAB AG; Bidder: Ephios Bidco GmbH
31.05.2024 / 08:35 CET/CEST
Dissemination of an announcement according to the German Securities Acquisition and Takeover Act (WpÜG), transmitted by EQS News - a service of EQS Group AG.
The bidder is solely responsible for the c...
Wed, 08.05.2024
SYNLAB delivers strong performance in Q1 2024
Revenue at €682 million
Strong underlying organic growth at 3.9% (Q1 2023: 10.0%); 5.2% adjusted for working days
Adjusted EBITDA at €123 million (increased by 4% compared to Q1 2023)
Strong Adjusted EBITDA margin at 18.0% (Q1 2023: 16.9%), at the upper end of the guided range for FY 2024 of 17-1...
Wed, 08.05.2024
SYNLAB delivers strong performance in Q1 2024
Revenue at €682 million
Strong underlying organic growth at 3.9% (Q1 2023: 10.0%); 5.2% adjusted for working days
Adjusted EBITDA at €123 million (increased by 4% compared to Q1 2023)
Strong Adjusted EBITDA margin at 18.0% (Q1 2023: 16.9%), at the upper end of the guided range for FY 2024 of 17-1...
Tue, 30.04.2024
SYNLAB Italy has restored operations after cyber-attack
SYNLAB Italy has restored operations and will gradually resume all services for patients and customers.
Due to a cyber-attack, SYNLAB had suspended operations in Italy as a precautionary measure.
SYNLAB Group confirms no impact on operations in other countries.
SYNLAB AG ("SYNLAB", FSE...
Information on product placements
